Detection rate of anterior prostate cancer in 226 patients submitted to initial and repeat transperineal biopsy

Urologia Internationalis

Volumn 93, Issue 2, 2014, Pages 189-192

  Pepe, Pietro ^a   Dibenedetto, Giuseppe ^a   Pennisi, Michele ^a   Fraggetta, Filippo ^a   Colecchia, Maurizio ^b   Aragona, Francesco ^a  

^a CANNIZZARO HOSPITAL   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Anterior prostate biopsy; Anterior prostate cancer; Saturation biopsy; Transperineal prostate biopsy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; KALLIKREIN; KALLIKREIN-RELATED PEPTIDASE 3, HUMAN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HEMATURIA; HEMOSPERMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATITIS; URINE RETENTION; BLOOD; CANCER GRADING; CANCER STAGING; LABORATORY DIAGNOSIS; LARGE CORE NEEDLE BIOPSY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROSPECTIVE STUDY; PROSTATE TUMOR; REPRODUCIBILITY;

AGED; BIOPSY, LARGE-CORE NEEDLE; FALSE NEGATIVE REACTIONS; HUMANS; KALLIKREINS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 84927969173     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000358494     Document Type: Article

References (25)

1. Center MM, Jemal A, Lortet-Tieulent J, et al: International variation in prostate cancer incidence and mortality rates. Eur Urol 2012; 61: 1079-1092.
2. Schröder FH, Hugosson J, Roobol MJ, et al: Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-1328.
3. Abouassaly B, Lane BR, Jones JS: Staging saturation biopsy in patients with prostate cancer on active surveillance protocol. Urology 2008; 71: 573-577.
4. Suardi N, Capitanio U, Chun FK, et al: Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features. Cancer 2008; 113: 2068-2072.
5. Pepe P, Garufi A, Priolo G, et al: Prostate cancer detection at repeat biopsy: can pelvic phased-array multiparametric MRI replace saturation biopsy? Anticancer Res 2013; 33: 1195-1199.
6. Pinto PA, Chung PH, Rastinehad AR, et al: Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol 2011; 186: 1281-1285.
7. Hambrock T, Somford DM, Hoeks C, et al: Magnetic resonance imaging-guided prostate biopsy in men with repeat negative biopsies and increased prostate-specific antigen. J Urol 2010; 185: 520-527.
8. Bott SRJ, Young MPA, Kellett MJ, et al: Anterior prostate cancer: is it more difficult to diagnose? BJU Int 2002; 89: 886-889.
9. Pepe P, Aragona F: Incidence of insignificant prostate cancer using free/total PSA: results of a case-finding protocol on 14,453 patients. Prostate Cancer Prostatic Dis 2010; 13: 316-319.
10. Pepe P, Aragona F: Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation. Urology 2007; 70: 1131-1135.
11. Pepe P, Fraggetta F, Galia A, et al: Is quantitative histologic examination useful to predict nonorgan-confined prostate cancer when saturation biopsy is performed? Urology 2008; 72: 1198-1202.
12. Lee AK, Doytchinova T, Chen M, et al: Can the core length involved with prostate cancer identify clinically insignificant disease in low risk patients diagnosed on the basis of a single positive core? Urol Oncol 2003; 21: 123-127.
13. Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213.
14. Al-Ahmadie HA, Tickoo SK, Olgac S, et al: Anterior-predominant prostatic tumors: zone of origin and pathologic outcomes at radical prostatectomy. Am J Surg Pathol 2008; 32: 229-235.
15. McNeal JE: The prostate and prostatic urethra: a morphologic synthesis. J Urol 1972; 107: 1008-1016.
16. Tiguert R, Kabbani W, Sakr W, et al: Origin and racial distribution of glandular tissue in the anterior compartment of the prostate: an autopsy study. Prostate 1999; 39: 310-315.
17. Fine SW, Reuter VE: Anatomy of the prostate revisited: implications for prostate biopsy and zonal origins of prostate cancers. Histopathology 2012; 60: 142-152.
18. Bouyé S, Potiron E, Puech P, et al: Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology. Prostate 2009; 69: 105-113.
19. Mai KT, Moazin M, Morash C, et al: Transitional zone and anterior peripheral zone of the prostate. A correlation of small-volume cancer in the biopsy cores and high PSA with positive anterior margins in radical prostatectomy specimens. Urol Int 2001; 66: 191-196.
20. Koppie TM, Bianco FJ Jr, Kuroiwa K, et al: The clinical features of anterior prostate cancers. BJU Int 2006; 98: 1167-1171.
21. Sundi D, Ross AE, Humphreys EB, et al: African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them? J Clin Oncol 2013; 31: 2991-2997.
22. Iremashvili V, Pelaez L, Jordá M, et al: Prostate cancers of different zonal origin: clinicopathological characteristics and biochemical outcome after radical prostatectomy. Urology 2012; 80: 1063-1069.
23. Komai Y, Numao N, Yoshida S, et al: High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. J Urol 2013; 190: 867-873.
24. Pepe P, Aragona F: Morbidity after transperineal prostate biopsy in 3000 patients undergoing
25. vs 18 vs more than 24 needle cores. Urology 2013; 81: 1142-1146.